| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.60B | 99.96B | 96.43B | 94.56B | 104.21B | 88.08B |
| Gross Profit | 29.53B | 33.69B | 28.75B | 24.51B | 30.17B | 25.91B |
| EBITDA | 17.93B | 22.02B | 17.78B | 14.25B | 19.04B | 16.32B |
| Net Income | 10.59B | 15.46B | 10.33B | 7.65B | 10.57B | 9.44B |
Balance Sheet | ||||||
| Total Assets | 153.24B | 168.34B | 153.94B | 150.54B | 138.03B | 129.16B |
| Cash, Cash Equivalents and Short-Term Investments | 40.39B | 48.80B | 43.31B | 38.43B | 36.84B | 37.02B |
| Total Debt | 8.23B | 7.73B | 8.40B | 8.51B | 8.58B | 16.89B |
| Total Liabilities | 35.96B | 41.02B | 38.33B | 40.77B | 38.48B | 45.26B |
| Stockholders Equity | 117.27B | 127.32B | 115.59B | 109.76B | 99.53B | 83.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.35B | 10.31B | 3.48B | 4.58B | 7.69B |
| Operating Cash Flow | 0.00 | 19.88B | 17.05B | 8.60B | 9.35B | 13.38B |
| Investing Cash Flow | 0.00 | -5.36B | -8.13B | -4.26B | -5.38B | -6.96B |
| Financing Cash Flow | 0.00 | -9.27B | -4.22B | -3.20B | -4.60B | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥240.85B | 15.02 | ― | 1.00% | 3.66% | 52.01% | |
73 Outperform | ¥321.38B | 10.92 | 5.47% | 3.41% | 0.55% | 25.37% | |
73 Outperform | ¥414.03B | 11.56 | 9.59% | 3.91% | -2.06% | 46.42% | |
67 Neutral | ¥286.05B | 12.02 | 1.47% | 4.29% | -5.02% | ― | |
63 Neutral | ¥340.55B | 16.55 | 9.45% | 2.65% | 1.87% | -5.06% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥331.26B | 34.75 | 9.34% | 4.27% | -1.18% | -78.57% |